Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Prosthesis Failure × Doxorubicin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 127 Lymphoma 89 Lymphoma, Large B-Cell, Diffuse 68 Sarcoma 55 Hodgkin Disease 40 Precursor Cell Lymphoblastic Leukemia-Lymphoma 33 Burkitt Lymphoma 31 Triple Negative Breast Neoplasms 27 Lymphoma, Non-Hodgkin 25 Lymphoma, Mantle-Cell 25 Lymphoma, Follicular 22 Leukemia 22 Neoplasms 19 Neoplasm Metastasis 18 Neuroblastoma 16 Multiple Myeloma 16 Ovarian Neoplasms 15 Carcinoma, Hepatocellular 15 Lymphoma, B-Cell 14 Prostatic Neoplasms 11 Liver Neoplasms 11 Urinary Bladder Neoplasms 10 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 10 Osteosarcoma 10 Lymphoma, Large-Cell, Anaplastic 10 Breast Neoplasms, Male 10 Lymphoma, Large-Cell, Immunoblastic 9 Dendritic Cell Sarcoma, Interdigitating 9 Inflammatory Breast Neoplasms 8 Lymphoma, T-Cell, Peripheral 7

Interventions

Radiotherapy 1 Paclitaxel 1 Doxorubicin 1 Cyclophosphamide 1 Cisplatin 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01918124 2018-10-12

EC-0701

Fudan University

Phase 2 Completed

Prosthesis Failure

Data powered by HemOnc (CC BY 4.0) Colophon ⚡